ArticleReviews in cardiovascular medicine2025
The Advanced Lung Cancer Inflammation Index Combined With Serum Chloride Levels Predicts the Risk of All-Cause Mortality in Patients With Acute Decompensated Heart Failure (ADHF): A Retrospective Study.
Article in Reviews in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Serum chloride levels and the advanced lung cancer inflammation index (ALI) score are independent prognostic factors in patients with heart failure (HF). Nevertheless, the interactive relationship between serum chloride levels and the ALI score in predicting all-cause mortality among individuals with acute decompensated heart failure (ADHF) remains undefined. Methods: The study recruited 1221 patients with ADHF who were hospitalized at the University Affiliated Hospital in China between January 2017 and October 2021. The ALI score was calculated as body mass index × serum albumin level/neutrophil-lymphocyte ratio (NLR), which was used to assess inflammation and nutritional status in ADHF patients. Results: Following adjustment for confounders including age, sex, New York Heart Association (NYHA) functional classification, left ventricular ejection fraction (LVEF), log-transformed brain natriuretic peptide (lgBNP), and C-reactive protein (CRP) levels, the independent association of ALI score (hazard ratio (HR): 0.984, 95% confidence interval (CI): 0.977-0.990; Conclusions: Combining the ALI score with serial serum chloride monitoring adds significant value in predicting all-cause mortality in ADHF patients who may benefit from aggressive chloride correction and anti-inflammatory therapies, potentially modifying the disease trajectory.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.